These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17649769)

  • 1. Preclinical and clinical effects of erythropoietin in the management of anaemia in patients with non-small cell lung cancer.
    Dempke W
    Anticancer Res; 2007; 27(4A):1745-57. PubMed ID: 17649769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
    Biesma B; van de Werf PR; Melissant CF; Brok RG
    Lung Cancer; 2007 Oct; 58(1):104-11. PubMed ID: 17601632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of epoetin in the management of anaemia in patients with lung cancer.
    Morère JF
    Lung Cancer; 2004 Nov; 46(2):149-56. PubMed ID: 15474662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC).
    Grossi F; Tiseo M
    Crit Rev Oncol Hematol; 2006 Jun; 58(3):221-30. PubMed ID: 16697211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of haemoglobin levels on prognosis and quality of life of patients with bronchial carcinoma].
    Drings P; Wannenmacher M
    Dtsch Med Wochenschr; 2005 Jun; 130(24):1507-11. PubMed ID: 15942841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early intervention with epoetin beta prevents severe anaemia in lung cancer patients receiving platinum-based chemotherapy: a subgroup analysis of the NeoPrevent study.
    de Castro J; Belda-Iniesta C; Isla D; Dómine M; Sánchez A; Batiste E; Barón MG
    Lung Cancer; 2008 Feb; 59(2):211-8. PubMed ID: 17875340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-operative plasma erythropoietin concentration and survival following surgery for non-small cell lung cancer.
    Paul I; Lappin TR; Maxwell P; Graham AN
    Lung Cancer; 2006 Mar; 51(3):329-34. PubMed ID: 16412529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin and chronic lymphocytic leukemia.
    Mauro FR; Gentile M; Foa R
    Rev Clin Exp Hematol; 2002; Suppl 1():21-31. PubMed ID: 12735212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-related leucocytosis and chemotherapy-induced neutropenia: linked or independent prognostic factors for advanced non-small cell lung cancer?
    Maione P; Rossi A; Di Maio M; Gridelli C
    Lung Cancer; 2009 Oct; 66(1):8-14. PubMed ID: 19328587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EPO in cancer anemia: benefits and potential risks.
    Milano M; Schneider M
    Crit Rev Oncol Hematol; 2007 May; 62(2):119-25. PubMed ID: 17197190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of anaemia in patients with malignancy: implications for the clinical use of recombinant human erythropoietin.
    Cazzola M
    Med Oncol; 2000 Nov; 17 Suppl 1():S11-6. PubMed ID: 11188780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Zealand cancer patients should have access to erythropoietin treatment.
    Carter J; Clay J
    N Z Med J; 2006 May; 119(1234):U1989. PubMed ID: 16718300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietic agents in the management of cancer patients. Part 1: Anemia, quality of life, and possible effects on survival.
    Smith RE
    J Support Oncol; 2003; 1(4):249-56, 258-9; discussion 257-8. PubMed ID: 15334867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New targeted therapies for non-small-cell lung cancer: a focus on the epidermal growth factor receptor.
    Crawford J
    J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S78-86. PubMed ID: 19795580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin and erythropoietin receptor coexpression is associated with poor survival in stage I non-small cell lung cancer.
    Saintigny P; Besse B; Callard P; Vergnaud AC; Czernichow S; Colombat M; Girard P; Validire P; Breau JL; Bernaudin JF; Soria JC
    Clin Cancer Res; 2007 Aug; 13(16):4825-31. PubMed ID: 17699861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European guidelines for the management of chemotherapy-induced anaemia and health economic aspects of treatment.
    Repetto L; Moeremans K; Annemans L;
    Cancer Treat Rev; 2006; 32 Suppl 2():S5-9. PubMed ID: 16725267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of maintenance chemotherapy in advanced nonsmall cell lung cancer.
    Jalal SI; Ademuyiwa FO; Hanna NH
    Curr Opin Oncol; 2009 Mar; 21(2):110-5. PubMed ID: 19532011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erythropoietic protein supportive treatment in small cell lung cancer].
    Tamási L; Müller V; Magyar P; Losonczy G
    Magy Onkol; 2008 Mar; 52(1):43-6. PubMed ID: 18403296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of smoking on histologic type and the efficacy of adjuvant chemotherapy in resected non-small cell lung cancer.
    Zhang Z; Xu F; Wang S; Li N; Wang C
    Lung Cancer; 2008 Jun; 60(3):434-40. PubMed ID: 18036699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New applications of erythropoietin in cardiovascular disease: from haematopoiesis to cardiac protection].
    van der Meer P; van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 2008 Apr; 152(16):923-7. PubMed ID: 18561787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.